Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Dr. Reddy's Laboratories is recalling Amlodipine Besylate and Atorvastatin Calcium tablets because the atorvastatin component is subpotent.
Dr. Reddy's Laboratories is recalling 1,056 bottles of Amlodipine Besylate and Atorvastatin Calcium tablets because the atorvastatin component is subpotent.
Reckitt Benckiser is recalling Mucinex Fast-Max DM Max bottles because the back label is missing active ingredients and safety warnings.
Taro Pharmaceuticals is recalling Topicort topical spray because impurity testing failed at 6 and 9 months. The recall covers 16,320 bottles distributed nationwide.
Dr. Reddy's Laboratories is recalling specific lots of Amlodipine Besylate and Atorvastatin Calcium tablets because they contain subpotent atorvastatin.
Dr. Reddy's Laboratories is recalling 576 bottles of Amlodipine Besylate and Atorvastatin Calcium tablets because the atorvastatin component is subpotent.
Dr. Reddy's Laboratories is recalling 984 bottles of Amlodipine Besylate and Atorvastatin Calcium tablets because the atorvastatin component is subpotent.
Dr. Reddy's is recalling Amlodipine Besylate and Atorvastatin Calcium tablets because the atorvastatin component was found to be subpotent.
KVK-Tech is recalling specific lots of Phentermine Hydrochloride Capsules because they failed impurity specifications during stability testing.
Dr. Reddy's is recalling specific lots of Amlodipine Besylate and Atorvastatin Calcium tablets because they contain subpotent atorvastatin.
Baxter Healthcare is recalling 189,120 bags of 0.9% Sodium Chloride Injection USP due to a customer complaint of an insect found inside a bag.
Mylan Institutional LLC is recalling 2,455 vials of Gemcitabine for Injection due to the presence of particulate matter.
Mylan Institutional LLC is recalling 10,094 vials of Gemcitabine for Injection due to the presence of particulate matter.
Baxter Healthcare is recalling 133,600 bags of 0.9% Sodium Chloride Injection USP due to the presence of an insect.
Mylan Institutional LLC is recalling specific lots of Gemcitabine for Injection due to the presence of particulate matter. The affected vials were distributed nationwide and in Puerto Rico.
Bausch & Lomb is recalling 13,995 bottles of Bromfenac Ophthalmic Solution, 0.09%, because preservative testing failed, raising concerns about sterility.
Mylan Institutional LLC is recalling Carboplatin Injection 450 mg/45 mL due to the presence of particulate matter.
GC Natural Nutrition is recalling PYROLA Advanced Joint Formula capsules because they contain undeclared prescription and over-the-counter drugs.
Wockhardt USA LLC is recalling 3,378 bottles of Lisinopril 20 mg tablets because an FDA inspection found inadequate investigations of past market complaints.
Wockhardt USA is recalling 1,704 bottles of Lisinopril 5 mg tablets because an FDA inspection found inadequate investigations of past market complaints.
UCB, Inc. is recalling Univasc (moexipril HCl) tablets because they failed 24-month dissolution testing. The recall covers 2,916 bottles distributed nationwide.
Vintage Pharmaceuticals LLC is recalling 360 bottles of Ampicillin Capsules, USP, 250 mg, because they are labeled with unapproved labeling.
Sun Pharma Global Fze is recalling 35,235 bottles of Bupropion Hydrochloride Extended-Release Tablets because they failed to meet drug release specifications during stability testing.
Mylan Institutional LLC is recalling Methotrexate Injection vials due to the presence of particulate matter.
James G. Cole, Inc. is recalling all Maxam brand products nationwide because they are misbranded, adulterated, and unapproved new drugs.